🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kathleen Fenn

ORCID: 0000-0001-6327-4365

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer”.

Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

Nature Cancer(2022)10.1038/s43018-022-00489-5

N/A

2.2DataRank · unranked

77 citations

Qingfei Pan, Codruța Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan +21 more

Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3567

N/A

0.104DataRank · unranked

1 citations

Veena Singh, Shing Mirn Lee, David Cieremans, Andrew B. Lassman, Dawn L. Hershman +12 more

Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat

medRxiv(2020)10.1101/2020.04.23.20066928

N/A

0DataRank · unranked

5 citations

Qingfei Pan, Cody Chiuzan, Maika Onishi, Mariano J. Alvarez, Erin Honan +17 more

Sequence-Specific Biosensors Report Drug-Induced Changes in Epigenetic Silencing in Living Cells

UNC Libraries(2020)10.17615/zgbz-8426

N/A

0DataRank · unranked

0 citations

Xudong Huang, Rammohan Narayanaswamy, Kathleen Fenn, Pilar Blancafort, Paul M. Lizardi +3 more

Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer

Clinical Breast Cancer(2022)10.1016/j.clbc.2022.04.002

N/A

0DataRank · unranked

18 citations

Kathleen Fenn, Matthew Kearney, Qi Wang, Hua Guo, Douglas K. Marks +11 more